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Barrier to autointegration factor (BAF) is a DNA-
binding protein found in the nucleus and cy-
toplasm of eukaryotic cells that functions to
establish nuclear architecture during mitosis.
Herein, we demonstrate a cytoplasmic role for
BAF in host defense during poxviral infections.
Vaccinia is the prototypic poxvirus, a family of
DNA viruses that replicate exclusively in the
cytoplasm of infected cells. Mutations in the
vaccinia B1 kinase (B1) compromise viral DNA
replication, but the mechanism by which B1
achieves this has remained elusive. We now
show that BAF acts as a potent inhibitor of pox-
virus replication unless its DNA-binding activity
is blocked by B1-mediated phosphorylation.
These data position BAF as the effector of an in-
nate immune response that prevents replication
of exogenous viral DNA in the cytoplasm. To en-
able the virus to evade this defense, the poxviral
B1 has evolved to usurp a signaling pathway
employed by the host cell.
INTRODUCTION
The barrier to autointegration factor (BAF) is an 89 amino
aciddimericDNA-bindingprotein found inboth thenucleus
and cytoplasm ofmany cell types. BAF has been shown to
participate in nuclear reorganization during mitosis and is
thought to facilitate nuclear reassembly by interacting
with both DNA and inner nuclear membrane proteins,
thus acting as a bridge to recruit chromatin to the nuclear
periphery (Furukawa et al., 2003; Haraguchi et al., 2001;
Margalit et al., 2005; Segura-Totten et al., 2002; Segura-
Totten andWilson, 2004; Shumaker et al., 2001). The con-
tribution of cytoplasmic BAF to cell function has remained
obscure, although it has been found to act as a retroviral
cofactor. Specifically, cytoplasmic BAF has been found
within retroviral preintegration complexes (PICs), where it
prevents autointegration of proviral DNA in vitro; a role
for BAF during the integration of the HIV and MLV proviral
DNA into the cellular genome may also occur, but is
currently somewhat controversial (Chen and Engelman,Cell H1998; Harris and Engelman, 2000; Jacque and Stevenson,
2006; Lee and Craigie, 1998; Lin and Engelman, 2003;
Shun et al., 2007). The roles of BAF both during normal
cell division and retroviral infection rely heavily on its ability
to bind double-stranded DNA in a sequence-independent
manner. This binding involves autonomous domains on
eachBAFmonomer (Bradley et al., 2005;Harris andEngel-
man, 2000; Segura-Totten et al., 2002; Zheng et al., 2000).
Given the fact that BAF participates in the process of
nuclear envelope assembly/disassembly during mitosis,
its temporal and/or spatial regulation by posttranslational
modifications has seemed likely. Indeed, we have recently
reported that the binding of BAF to DNA in vitro is strongly
inhibited upon the phosphorylation of its N terminus by the
cellular vaccinia-related kinases VRK-1 and VRK-2 (Nich-
ols et al., 2006). The sites on which BAF is phosphorylated
by VRKs are highly conserved in diverse eukaryotes and
can be similarly phosphorylated in vitro by the closely re-
lated B1 protein kinase encoded by vaccinia virus (Nichols
et al., 2006). (The nomenclature B1, which has been used
in the literature, refers to the fact that this viral protein is
encoded by the first ORF in the HindIII B fragment of the
viral genome; since the complete sequence of the WR
strain has been completed, the nomenclature WR183
has also been introduced for this gene.) However, a role
for BAF phosphorylation during poxviral infection has not
been elucidated.
Vaccinia is the prototypic member of the poxvirus fam-
ily, which comprises complex DNA viruses whose more
notorious members include the etiological agents of
smallpox and monkeypox. These DNA viruses are unique
in that they replicate exclusively in the cytoplasm of in-
fected cells. The vaccinia B1 kinase is an essential protein
that is expressed at early times after infection and encap-
sidated at low levels in nascent virions (Banham and Smith,
1992; Lin et al., 1992; Rempel and Traktman, 1992). Impor-
tantly, mutations which disrupt B1 compromise viral DNA
replication and therefore the production of infectious virus
(Boyle and Traktman, 2004; Rempel et al., 1990; Rempel
and Traktman, 1992). The mechanism through which B1
contributes to DNA replication remains elusive, as it
does not appear to phosphorylate any of the known com-
ponents of the viral replication machinery (Boyle and
Traktman, 2004 and P.T., unpublished data). However,
since a B1 defect can be complemented by expression
of hVRK1 from the viral genome (Boyle and Traktman,ost & Microbe 1, 187–197, May 2007 ª2007 Elsevier Inc. 187
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phorylate BAF in vitro (Nichols et al., 2006), it seemed
plausible to propose an important role for B1-mediated
phosphorylation of BAF during vaccinia infection.
RESULTS
BAF Phosphorylation Increases
during Vaccinia Infection
To first investigate whether BAF is phosphorylated during
poxviral infections, we expressed BAF as a 3X-FLAG
fusion protein, either transiently in U2OS or BSC40 cells,
or stably by engineering a novel derivative of tetra-
cycline-inducible 293 cells (293:BAF). In uninfected cells,
BAF appears as two closely migrating forms in immuno-
blot analysis (Figure 1A). Only the more slowly migrating
form is radiolabeled when transfected cells are incubated
in the presence of 32PPi, indicating that the posttransla-
tional modification induces a shift in BAF’s electrophoretic
mobility (Figure 1A, lane 2, U2OS lysates; Nichols et al.,
2006). When all three cell lines were infected with wild-
type (wt) vaccinia virus, the proportion of BAF present as
the phosphorylated form increased, as did the intensity
of the 32P signal in the labeled U2OS cells (lane 3). To ex-
amine whether this phosphorylation was indeed mediated
by the virally encoded B1 kinase, we utilized the ts2 tem-
perature sensitive mutant, which has a point mutation in
the B1 locus that greatly diminishes both the catalytic ac-
tivity and stability of the protein (Rempel and Traktman,
1992). Importantly, the phosphorylation of BAF failed to
increase during nonpermissive infections with ts2 (Fig-
ure 1A, compare lanes 2 and 4), supporting the conclusion
that B1 phosphorylates BAF in vivo. To confirm that the
lack of BAF phosphorylation under these conditions was
a direct consequence of B1’s inactivation, rather than an
indirect effect of the subsequent arrest of the viral life cy-
cle, we mimicked the latter by performing infections with
wt virus in the presence of cytosine arabinoside (araC).
Under these circumstances, in which B1 is active but
postreplicative events are blocked (Oda and Joklik,
1967), the increased phosphorylation of cytoplasmic
(soluble) BAF was still observed (Figure 1B, compare
lanes 1 and 3 with 5 and 7). Finally, we monitored the
phosphorylation status of BAF following infection with
ts2/hVrk1, a derivative of ts2 that has been complemented
by the insertion of the human Vrk1 cDNA (Boyle and Trakt-
man, 2004). Following infection with ts2/hVrk1, the pro-
portion of BAF in the phosphorylated form also increased
(Figure 1A, compare lanes 5 and 3).
To verify that our observations using FLAG-tagged BAF
were also observed with endogenous BAF, we examined
the phosphorylation of both the endogenous and exoge-
nous BAF proteins during vaccinia infections. This was
accomplished using an antibody that we generated which
specifically recognizes BAF molecules containing a phos-
phate moiety on Ser4, the site preferentially modified by
B1 and VRK1 in vitro and in vivo (Nichols et al., 2006)
(see Figure S1 in the Supplemental Data available with
this article online.). Indeed both FLAG-BAF and endoge-188 Cell Host & Microbe 1, 187–197, May 2007 ª2007 Elseviernous BAF showed a robust shift to the phosphorylated
form soon after infection with wt virus (Figure 1C, compare
lanes 1 and 2), but not after ts2 infection (compare lanes 2
and 5). More specifically, quantitation of endogenous BAF
modification at 2 hpi revealed a 10-fold greater phosphor-
ylation during wt versus ts2 infection. These data confirm
that, in the context of viral infection, expression of B1 (or
VRK1) from the cytoplasmic viral genome leads to an
increase in the fraction of BAF that is phosphorylated.
BAF Associates with Viral DNA Replication Sites
in the Absence of the B1 Kinase
We next sought to understand how phosphorylation of
BAF might be important during vaccinia infection. In light
of the fact that (1) the ability of BAF to bind DNA is strongly
inhibited by phosphorylation, and (2) a catalytically active
B1 kinase is needed for ongoing viral DNA replication, we
hypothesized that unphosphorylated, cytoplasmic BAF
would bind to vaccinia DNA upon its release from the viral
core into the cytoplasm. This uncoating event occurs after
the phase of early viral gene expression and enables DNA
replication to commence. Once BAF would have access
to the released genome, its ability to crossbridge DNA
(Bradley et al., 2005; Suzuki and Craigie, 2002) might, in
essence, lead to a sequestering of the genome that would
block replication. This model would be consistent with the
observation that catalytically active hVRK1, but not an
inactive variant, rescues the replication defect of ts2
(Boyle and Traktman, 2004). Based on this hypothesis,
we first predicted that BAF would be recruited to viral
DNA replication sites during a nonpermissive ts2 infection
(39.7C), but not during an infection with wt virus or with
ts2 at the permissive temperature (31.5C). 293 cells
stably expressing FLAG-BAF were utilized to study BAF
localization, because the anti-BAF antibodies that are
available cannot be used to detect endogenous BAF by
immunofluorescence. FLAG-BAF was found in both the
nucleus and the cytoplasm (Figure 2A), as has been previ-
ously observed for the endogenous protein (Haraguchi
et al., 2001; Segura-Totten et al., 2002). These cells
were then infected with wt vaccinia virus and the intra-
cellular localization of FLAG-BAF was assessed. At 9 hpi,
the protein was present throughout the cell (Figure 2C),
exhibiting no colocalization with, or concentration at, the
cytoplasmic sites of viral replication, which were visual-
ized both by DAPI staining (Figure 2E) and with an anti-
body specific for the viral single strand DNA-binding
protein (I3) (arrowheads, Figure 2D) (Rochester and Trakt-
man, 1998). We next monitored the localization of BAF
following infection with ts2 for 9 hr at the permissive tem-
perature; under these conditions, BAF retains a diffuse
localization in the great majority of cells (Panel F). How-
ever, in keeping with the fact that the phenotype of ts2 is
not fully wild-type even at the permissive temperature
(Rempel et al., 1990), we did observe colocalization of
BAF with 10%–15% of the replication sites (arrows, Fig-
ures 2F–2H). To examine whether BAF would consistently
localize with foci of viral DNA during nonpermissive ts2 in-
fections, we performed the initial 7 hr of infection at theInc.
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Vaccinia Infection in a B1-Dependent
Manner
BSC40, U2OS, and 293:BAF cells were engi-
neered to express FLAG-BAF either through
transient transfection (BSC40 and U2OS) or
TET induction (293:BAF cells). Cells were left
uninfected or infected for 5 hr with wild-type
vaccinia virus, ts2, or ts2/hVrk1 at 39.7C, as
shown (MOI = 10).
(A) Lysates were prepared from all cells using
0.5% Triton X-100. The U2OS cells were meta-
bolically labeled with 32PPi for 5 hr prior to
harvest, and the BAF was retrieved by immu-
noprecipitation with rabbit a-FLAG antibody.
These immunoprecipitates, and the soluble ly-
sates prepared from the other cell lines, were
resolved by SDS-PAGE and either subjected
to immunoblot analysis with the M2 a-FLAG
antibody or visualized by autoradiography
(top panel only). Open and filled triangles indi-
cate unphosphorylated and phosphorylated
BAF, respectively.
(B) BSC40 cells expressing FLAG-BAFwere in-
fected ± 20 mMAraC. Lysates were prepared in
the presence of 0.5% Triton X-100 as in (A),
and the BAF protein in both the soluble (S)
and insoluble (P) fraction was visualized by
immunoblot analysis.
(C) 293:BAF whole cell lysates were harvested
at the indicated time postinfection. Endoge-
nous BAF and FLAG-BAF were detected either
with an antibody specific to the N terminus of
BAF or M2 antibody, respectively. Phosphory-
lated endogenous BAF and phosphorylated
FLAG-BAF were detected using an antibody
raised against a BAF peptide phosphorylated
at Ser-4. Vaccinia I3 was detected using a-I3
serum.lines, the rate of DNA synthesis during ts2 infections waspermissive temperature so that replication would begin
and macromolecular sites of DNA accumulation would
form, and then shifted the cultures to the nonpermissive
temperature for an addition 2 hr. Importantly, this ‘‘shift-
up’’ protocol leads to the cessation of viral DNA synthesis
within 30 min (Rempel and Traktman, 1992). When these
cultures were examined, we saw a striking colocalization
of BAFwith90%of the viral DNA replication sites (arrows
in the three examples shown in Figures 2I–2Q). Together,
these data are consistent with a model in which BAF
remains diffuse during wt infection, when it is fully phos-
phorylated by B1 and hence does not bind to viral DNA.
In contrast, under conditions where active B1 is lacking,
the vast majority of BAF remains unphosphorylated and
therefore binds to viral DNA replication complexes.
We next examined the rate of DNA accumulation in
these same 293:BAF cells using the identical ‘‘shift up’’
protocol. This experiment has previously been performedCell Hin L929 cells, in which a shift to the nonpermissive temper-
ature during ts2 infection results in a precipitous drop in
the rate of DNA replication while no change is observed
during wt vaccinia infection (Rempel and Traktman,
1992). To determine whether this also occurs in 293:BAF
cells and would coincide with the relocalization of BAF
to sites of viral DNA replication, we infected 293:BAF cells
at 31.5C with wt virus and ts2. The amount of viral DNA
was assessed at 3, 7, 9, and 12 hpi by dot blot hybridiza-
tion; we examined infections which were either performed
entirely at 31.5C or shifted to 39.7C at 7 hpi, a protocol
which mirrors the procedure used in the immunofluores-
cence studies (Figure 2). We observed that during wt
infection, there was no difference in the rate of DNA syn-
thesis in infections performed at 31.5C versus those
shifted to 39.7C (Figure 3A, solid black versus dashed
black lines). In contrast, as has been seen in other cellost & Microbe 1, 187–197, May 2007 ª2007 Elsevier Inc. 189
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pare solid graywith solid black lines). Moreover, the rate of
DNA synthesis slowed significantly after the cultures were
shifted to 39.7C (compare solid gray versus dashed gray
lines). These data demonstrate that the relocalization of
BAF to the sites of viral DNA accumulation which is seen
when ts2 infections are shifted to 39.7C (Figure 2) is
correlated with an inhibition of further DNA replication.
Increased BAF Levels Correlate with DecreasedDNA
Synthesis In Vivo and In Vitro
If BAF is capable of inhibiting viral DNA synthesis, an in-
verse correlation should exist between the abundance of
Figure 2. BAF Colocalizes with Vaccinia DNA Replication
Sites in the Absence of Functional B1, but Not during Infec-
tions with WT Virus
293:BAF cells were induced to express FLAG-BAF and left uninfected
(A and B) or then infected (MOI = 5) with wt virus at 31.5C for 7 hr
followed by a shift to 39.7C for an additional 2 hr (C–E), ts2 at
31.5C (F–H), or ts2 at 31.5C for 7 hr followed by a shift to 39.7C
for an additional 2 hr (3 examples in I–K, L–N, and O–Q). At 9 hpi, cells
were fixed and proteins visualized with M2 a-FLAG and a-I3 primary
antibodies followed by fluorescent secondary antibodies. Arrowheads
indicate viral DNA replication sites that exhibit no BAF colocalization,
whereas arrows indicate replication sites that do showBAF colocaliza-
tion. DNA was visualized using DAPI. Scale bars represent 50 mm in
(A and B) and 25 mm in (C–Q).190 Cell Host & Microbe 1, 187–197, May 2007 ª2007 ElsevieBAF in the cytoplasm and the levels of viral DNA that are
produced. To test this prediction, we compared DNA ac-
cumulation during infections performed with wt virus or
ts2 in the control 293:CAT cell line and the 293:BAF cell
line, each of which had been grown in 1 mg/ml tetracycline.
In all cases, infections were performed at 31.5C for 7 hr,
and then shifted to 39.7C. For both viruses, BAF overex-
pression correlated with a reduction of the amount of viral
DNA that had accumulated at each time point assayed
(Figure 3B). At 12 hpi, the amount of DNA accumulated
in 293:BAF cells infected with wt virus (black solid line)
was 70% of that seen in 293:CAT cells (gray solid line).
The impact of BAF overexpression on ts2 was more dra-
matic: the amount of DNA seen in 293:BAF cells at 12
hpi was only 33% of that found in the 293:CAT cells (com-
pare the black and gray dashed lines).
We hypothesized that the recruitment of BAF to the sites
of DNA synthesis and the subsequent inhibition of DNA
replication was mediated by direct binding of nonphos-
phorylated BAF to viral DNA. Although several studies
characterizing the BAF-DNA interaction have been pub-
lished, the implications of this interaction on transcription
or replication of the coated DNA have not been ad-
dressed. To assess whether BAF-bound DNA could still
serve as a replication template, E. coli DNA polymerase I
and plasmid DNA were incubated in standard nick trans-
lation reactions in the presence of increasing concentra-
tions of either unphosphorylated or phosphorylated BAF.
When increasing amounts of unphosphorylated BAF
were added to the DNA template for 10 min prior to the
addition of DNA Polymerase I, there was a sharp, dose-
dependent decrease in the amount of nascent DNA syn-
thesis (Figure 3C). However, when the same experiment
was performed using a BAF preparation that had been
stoichiometrically phosphorylated by the B1 kinase, DNA
synthesis proceeded unabated. These data clearly dem-
onstrate that, when it is not phosphorylated, the direct
interaction of BAF with DNA can act as a potent inhibitor
of DNA synthesis.
Overexpression of BAF Reduces Viral Yield;
shRNA-Mediated Depletion of BAF Rescues the
Temperature-Sensitive Phenotype of ts2
Since overexpression of BAF reduces viral DNA replica-
tion, it seemed reasonable to predict that it might also af-
fect virus production, and so exacerbate the temperature-
sensitivity of ts2. 293 cells induced to express FLAG-BAF
or the chloramphenicol acetyltransferase (CAT) protein
(control) were infected with wt virus or ts2 at both
31.5C and 39.7C, and the yield of infectious virus was
determined at 24 hpi (Figure 4A). Under the conditions
used, this induction resulted in a 4- to 5-fold overexpres-
sion of FLAG-BAF versus endogenous BAF, as deter-
mined by quantitative immunoblot analysis (representa-
tive experiment shown in Figure 4B). While wt vaccinia
virus produced comparable yields in 293:CAT cells at
both temperatures, 3-fold less progeny were produced
in 293:BAF at 39.7C than at 31.5C, indicating that over-
expression of BAF might be somewhat inhibitory even inr Inc.
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(A and B) Relative rates of viral DNA accumulation were assessed by
dot blot hybridization of cell lysates following wt and ts2 infection. In
(A), infections were initated in 293:BAF cells at 31.5C; infected cells
were either left at that temperature throughout the experiment or
shifted to 39.7C at 7 hpi. In (B), both 293:CAT and 293:BAF cells
were used and all infections were shifted to 39.7C at 7 hpi. Duplicate
experiments were performed and analyzed in triplicate; the average
values are shown, with standard errors indicated.
(C) Nick translation reactions were preincubated with unphosphory-
lated or phosphorylated BAF prior to the addition of E. coli Pol I for 1
hr, and the incorporation of radiolabeled dNTPs into DNA was mea-
sured. The average of two experiments is shown as percent efficiency
compared to reactions with no BAF with standard errors shown.Cellthe presence of an active B1 kinase. This conclusion is
supported by our finding (see Figure 3) that the levels of
DNA synthesized by wt virus were reduced when BAF
was overexpressed. The expected temperature sensitivity
of ts2 was evident in the control 293:CAT cell line, in which
the yield of virus produced at 39.7Cwas only 6.5%of that
produced at 31.5C; this phenotype is comparable to
what has been previously observed in BSC40 cells (Boyle
and Traktman, 2004). Even at the permissive temperature,
the viral yield in the cells overexpressing BAF was 3-fold
less than what was seen in the control cells. The temper-
ature sensitivity of the virus was also exacerbated: in the
293:BAF cells, the yield of virus produced at 39.7C was
only 1.6% of that produced at 31.5C. Furthermore,
when DNA replication was monitored in 293:BAF cells in-
fected at 39.7C, the levels of DNA that accumulated in
ts2-infected cells was only 7% of that seen in wt-infected
cells (Figure S2). These data indicate that when the B1
kinase is impaired and the levels of BAF are elevated,
completion of a productive infectious cycle is impaired.
If unphosphorylated BAF represents a barrier to
infection, then its absence should rescue the tempera-
ture-sensitivity of ts2 infections. We therefore generated
replication-incompetent lentiviruses that would allow
shRNA-mediated depletion of endogenous BAF. Cells
were treated with a control lentivirus, a lentivirus encoding
a scrambled shRNA with no target specificity, or a lentivi-
rus encoding an shRNA whose sequence is known to
target BAF efficiently (Jacque and Stevenson, 2006).
Using the latter lentivirus, we consistently observed an
85% decrease in the levels of endogenous BAF at 96
hpi (Figure 4C). After this pretreatment, each of the cul-
tures was infected with wt vaccinia virus or ts2 at both
31.5C and 39.7C, and the yield of viral progeny was
determined after 24 hr (Figure 4D). Wt virus produced
comparable viral yields under all conditions. The temper-
ature sensitivity of ts2 was clearly observed in both of
the control cell lines, with the yield of virus obtained at
39.7Cbeing <8%of that produced at the permissive tem-
perature. However, in the shBAF-treated cells, the yield of
virus produced by ts2 at the nonpermissive temperature
was dramatically increased to 41% of that produced at
the permissive temperature. Stated another way, in the
context of a defective B1 kinase, a 6.7-fold reduction in
BAF levels led to a 14-fold increased in virus production
at 39.7C. Clearly, depletion of BAF leads to a near rever-
sal in the temperature-sensitive defect of ts2.
Unphosphorylatable BAF Cannot Be Expressed
from the Viral Genome
Our final prediction was that, if depletion or phospho-
rylation of BAF is a prerequisite for efficient viral DNA
replication, then the cytoplasmic expression of a nonphos-
phorylatable variant of BAF should inhibit viral replication.
We previously identified such a variant during our charac-
terization of B1- and VRK1-mediated phosphorylation of
BAF (Nichols et al., 2006). The BAF-MAAAQ protein, in
which the B1 target sites Thr-2, Thr-3, and Ser-4 have
been replaced with alanine, is no longer modified by B1Host & Microbe 1, 187–197, May 2007 ª2007 Elsevier Inc. 191
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BAF from the Cellular Genome Exacer-
bates the ts2 Phenotype, while shRNA-
Directed Depletion of BAF Rescues the
ts2 Phenotype
(A and B) 293:CAT or 293:BAF cells were
grown in media containing tetracycline for 6
days and either harvested for immunoblot
analysis using a rabbit aBAF antibody (B) or
plated in fresh media containing TET and
then infected with wt virus or ts2 (MOI = 5) at
31.5 or 39.7C (noted as 32 and 40C for sim-
plicity) (A). All infections were harvested at
24 hpi and viral yield was determined. For each
cell line, the yield of ts2 obtained at 39.7C is
expressed as a percent of that obtained at
31.5C.
(C and D) 293 cells stably expressing shRNAs
for 96 hr were either (C) harvested for immuno-
blot analysis using a rabbit aBAF antibody
(total protein visualized using Coomassie) or
(D) infected with wt virus or ts2 for 24 hr as
described above. All data represent viral yields
from infections titrated in duplicate or triplicate,
with standard errors shown.(or hVRK1) and retains DNA-binding activity in the pres-
ence of the kinase. These N-terminal amino acid substitu-
tions prevent the phosphorylation of BAFwithout affecting
its intrinsic DNA-binding activity or its stability in vivo. To
compare the impact of wt BAF and BAF-MAAAQ on the
vaccinia life cycle, we attempted to generate viral re-
combinants expressing these proteins. The pJS4-RFP
plasmid (shown in Figure 5A), contains 2 divergent vac-
cinia promoters, one of which was used to drive the ex-
pression of RFP (red fluorescent protein), and the second
to express the relevant BAF protein. Sequences derived
from each half of the vaccinia TK locus flank this cassette
and enable its stable insertion into the viral genome via ho-
mologous recombination. This recombinational insertion
leads to the inactivation of the TK locus, which in turn ren-
ders the virus resistant to bromodeoxyuridine (BrdU).
Cells were infected with wt virus and transfected with
linearized plasmid, the expression of which was verified
by RFP fluorescence in the initial transfection (data not
shown). The viral yield from these infections/transfections
was passaged in the absence or presence of BrdU (to
amplify all the virus present or to select for TK viruses,192 Cell Host & Microbe 1, 187–197, May 2007 ª2007 Elsevierespectively). In the absence of BrdU selection, all three
stocks contained a similar viral titer (Figure 5B). The total
viral yield decreased markedly following BrdU selection,
but equivalent titers were obtained from infections/
transfections involving plasmids expressing RFP alone
or RFP and wt BAF. Moreover, a significant fraction of
these TK plaques were red, confirming that their BrdU-
resistance was a result of integration of the RFP (or
RFP4BAF)-expressing cassette rather than the acquisi-
tion of random mutations that had inactivated the TK
locus. Viruses expressing wt BAF were isolated at a lower
frequency than those expressing RFP alone, suggesting
that constitutive expression of BAF may render these vi-
ruses somewhat less fit, although this possibility has not
been explored further. Nonetheless these viruses could
be readily generated, and the expression of BAF from their
genome was verified by immunoblot analysis (Figure S3).
We also attempted to insert the RFP or RFP4BAF cas-
sette into the ts2 genome at 31.5C. While ts2 viruses
expressing RFP alone were readily isolated, red plaques
that were presumed to contain the RFP4BAF cassette
were 25% of the size of nonred plaques and could onlyr Inc.
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fore infectivity was lost. Presumably, even at the permis-
sive temperature, the compromised B1 protein produced
by ts2 was insufficient to overcome the repression medi-
ated by overexpression of BAF from the viral genome.
Our attempts to isolate wt viruses containing the
RFP4BAF MAAAQ cassette proceeded far differently
than had our successful efforts to generate viruses
expressing RFP or RFP + wt BAF (see above). Only 10%
asmuch virus was recovered after passage of the progeny
obtained from the infection/transfection in the presence of
BrdU, and none (0 of 332) of these TK plaques were red
(Figure 5B). The inability to obtain recombinants express-
ing BAFMAAAQ strongly supports the conclusion that the
expression of a nonphosphorylatable derivative of BAF in
the cytoplasm is lethal for the virus, presumably as a result
of sequestration of the viral genome.
Figure 5. A Nonphosphorylatable Derivative of BAF Is Lethal
for Viral Infection When Expressed from the Viral Genome
(A and B) Expression of BAF from the viral genome: Linearized pJS4 
RFP, RFP +BAF, and RFP +MAAAQplasmid DNAwas introduced into
BSC40 cells previously infected with wt vaccinia virus (MOI = 0.03),
and recombinational insertion of the transcriptional cassette into the
viral TK locus was allowed to proceed during 2 days of incubation.
One passage was then performed in human TK cells ± BrdU to select
for TK-deficient virus. The viral yield was then determined by titration
on BSC40 cells, and red fluorescent plaques were counted to deter-
mine the number of TK viruses expressing RFP, and by inference,
BAF or BAF-MAAAQ. The frequency of red plaques obtained in each
of the three experiments was compared in pairwise fashion, and the
difference between each was found to be significant using a Fisher’s
exact test (p < 0.0001).CellDISCUSSION
The cellular BAF protein is known to play important roles in
regulating nuclear architecture during the cell cycle via in-
teractions with DNA and inner nuclear membrane proteins
containing LEM domains. BAF’s closest relative, BAF-like
protein (BAF-L) has 40%homolog to BAF, but appears un-
able to bind DNA or LEM domains, indicating that these
are attributes unique to BAF (Tifft et al., 2006). In addition
to its nuclear localization, BAF has been observed in the
cytoplasm of interphase cells (Segura-Totten and Wilson,
2004), although it has been unclear how this pool of BAF
contributes to cellular function. However, early in our stud-
ies we made the observation that transiently expressed
GFP-BAF could be seen to colocalize with transfected
DNA, which formed DAPI-positive speckles in the cyto-
plasm. These data suggested that cytoplasmic BAF can,
and does, recognize and bind to DNA (M.S.W and P.T.,
unpublished data).
It has become clear that BAF’s functions within the cell
are regulated by phosphorylation. We have shown that the
nuclear VRK1 kinase phosphorylates BAF in vitro and in
mammalian cell culture, regulating its DNA-binding activ-
ity, its interaction with LEM domains, and its intracellular
localization (Bengtsson and Wilson, 2006; Nichols et al.,
2006). The interplay of VRK and BAF has recently been
found to be operative in C. elegans as well, where is ap-
pears to regulate the association of BAF with chromatin
during nuclear reassembly at the end of mitosis (Gorja-
nacz et al., 2007). Interestingly, the VRK kinases are
closely related to the B1 kinase encoded by the vast ma-
jority of poxviruses, which are complex DNA viruses that
replicate exclusively in the cytoplasm of infected cells.
The fact that VRK1 can complement the replication defect
of a B1 mutant of vaccinia virus indicates that the viral and
cellular kinases share functional as well as structural sim-
ilarity, and indeed B1 retains the ability to repress BAF’s
DNA-binding capability in a manner that is nearly indistin-
guishable from VRK (Nichols et al., 2006).
Based on these observations, we postulated that the
DNA-binding activity of cytoplasmic BAF might represent
a novel, intrinsic host defense against the expression of
foreign DNA. Because VRK1 shows a nuclear localization,
and is not available tophosphorylate cytoplasmicBAF (Lo-
pez-Borges and Lazo, 2000; Nichols and Traktman, 2004),
we reasoned that the viral B1 kinase had evolved to target
the same residues on BAFwhich would be targeted VRK1.
B1 is both encapsidated in vaccinia virions and expressed
immediately upon infection (Banham and Smith, 1992;
Lin et al., 1992; Rempel and Traktman, 1992), and is there-
fore poised to phosphorylate BAF and block its ability to
bind to the viral genome as it is released from the core,
allowing viral DNA replication to proceed efficiently.
In this report, we have demonstrated that endogenous
BAF is indeed phosphorylated in a B1-dependent manner
during vaccinia virus infections, as is a stably expressed
epitope-tagged BAF. When active B1 is present, this epi-
tope-tagged BAF is found throughout the cell; however,
when infection proceeds in the presence of an impairedHost & Microbe 1, 187–197, May 2007 ª2007 Elsevier Inc. 193
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sites at which viral DNA has accumulated. This localization
correlateswith a diminution of further viral DNA replication.
Overexpression of BAF exacerbates the temperature-
sensitive phenotype of the ts2 mutant, greatly reducing
DNA synthesis and further diminishing virus production at
the nonpermissive temperature. Indeed, the overexpres-
sion of BAF has a dampening effect on viral DNA replica-
tion and the production of infectious progeny even in the
presence of a wild-type B1 kinase. Our hypothesis that
the association of BAF with viral DNA in vivo would impair
replication, and perhaps transcription, is supported by our
demonstration that BAF inhibits DNA synthesis in vitro in
a dose-dependent manner. Phosphorylated BAF, which
lacks DNA-binding activity, has no such effect. Finally,
while it remains possible that BAF also inhibits the activity
of vaccinia proteins in vivo through direct protein:protein
interactions, our in vitro studies utilized no viral proteins,
demonstrating that BAF’s repressive ability relies only on
its interaction with DNA.
To complement our analysis of the impact of BAF over-
expression, we utilized shRNA technology to assess the
impact of BAF depletion. Depletion of BAF had a striking
effect, leading to a near reversal of the temperature-sensi-
tive phenotype of the ts2mutant. These data imply that the
primary and most vital role played by the B1 kinase during
the vaccinia virus life cycle is to overcome the repressive
effect of BAF.
As another test of whether phosphorylation of BAF was
as vital as it appeared to be for efficient viral replication,
we attempted to generate viral recombinants expressing
wt BAF or a nonphosphorylatable derivative of BAF. While
viruses expressing BAFwere readily isolated, we were un-
able to isolate any recombinants expressing the BAF-
MAAAQ derivative. The expression of nonphosphory-
latable BAF from the viral genome, where it is translated
in close proximity to the viral genome, is in fact lethal to
the virus.
Cells have numerous mechanisms at their disposal to
detect invaders, but viruses have evolved equally numer-
ous countermeasures that enable them to direct success-
ful infections. It is the efficiency with which these counter-
measures work that often defines the host range of a
particular virus. Interestingly, molluscum contagiosum
virus (MCV) is the only poxvirus that lacks a B1 homolog,
and this virus exhibits a very narrow host range. It is only
able to replicate in the stratified epithelium of human
skin, and has not been successfully passaged in any cell
culture system (Birthistle and Carrington, 1997). We spec-
ulate that the keratinocyte layer that is permissive for MCV
infection may either have very low levels of cytoplasmic
BAF or contain a cytoplasmic pool of a kinase (like VRK)
that can phosphorylate and neutralize BAF. Alternatively,
MCV may encode an as yet unknown protein that over-
comes BAF via a distinct mechanism.
This duel between BAF and B1 is a newly identified ex-
ample of the intricate interplay between pathogens and
their hosts. Among themost well-characterizedmediators
of this innate surveillance against infection are the toll-like194 Cell Host & Microbe 1, 187–197, May 2007 ª2007 Elsevierreceptors, which are capable of responding to a variety of
foreign molecules including DNA and RNA (Vasselon and
Detmers, 2002). However, the absence of TLRs frommost
nonimmune cells has stimulated speculation that other
sensors of foreign nucleic acid must exist (Ishii et al.,
2006; Stetson and Medzhitov, 2006; Wagner and Bauer,
2006). Indeed, the elucidation that the RNA helicase
RIG-I can act as a cytoplasmic RNA sensor, and indeed
can trigger the downstream activation of host response
genes indicates that this is true (Meylan and Tschopp,
2006). Because BAF is a highly conserved protein (Fig-
ure S4) found in all eukaryotic dividing cells that have
been tested (Mansharamani et al., 2003) and because it
binds DNA avidly and without regard to sequence speci-
ficity, our findings raise the possibility that BAF might be
a central component of a widespread host defense which
recognizes and silences foreign DNA. It will be of signifi-
cant interest to determine whether, subsequent to its
binding to foreign DNA, BAF may function like RIG-I and
contribute to a signaling cascade that alerts cells of a
possible infection.
EXPERIMENTAL PROCEDURES
Cloning and Production of Stable Cell Lines
pcDNA5/FRT/TO/3XFLAG-BAF was constructed by amplifying the
Baf alleles from p3XFLAG-BAF (Nichols et al., 2006) with the pri-
mers FLAGBAF-UPBam (50-GAGGGTACCGGATCCGCACCATGGACTA
CAAA-30) and BAF-DN. This places a BamHI sequence (underlined)
both upstream and downstream of the ORF, which were used to clone
into the BamHI site present in the pcDNA5/FRT/TO.
Stable integration of CAT and 3XFLAG-BAF in 293 cells was accom-
plished using the Flp-In System (Invitrogen, Carlsbad, CA), which em-
ploys 293 Trex cells (Invitogen) containing two stably integrated plas-
mids. The first plasmid pcDNA6/TR constituitively expresses TetR;
a single integrated copy of the second plasmid pFRT/lacZeo contains
the yeast FRT recombination site. These cells were co-transfected
with pcDNA5/FRT/TO-CAT or 3XFLAG-BAF and pOG44, a plasmid
expressing the S. cerevisiae Flp recombinase. Expression of Flp medi-
ates a single recombination event between the FRT site in pcDNA5/
FRT/TO plasmids and the FRT site integrated into the 293 genome,
thus ensuring that the resulting 293:CAT and 293:BAF cells express
each of their exogenous genes from a single copy at the same genetic
locus. Properly targeted cells are selected by growth in 100 mg/ml hy-
gromycin and 15 mg/ml blasticidin; expression is uniform because all
cells express the protein from a single copy of a cDNA inserted at the
same genomic locus under the regulation of the same promoter.
Cloning and Production of Recombinant Viruses
pJS4-RFP-BAF and -MAAAQ were constructed by amplifying the Baf
alleles from p3XFLAG-BAF and p3XFLAG-BAF-MAAAQ with the
primers FLAG-BAF-UPXho (50-CAGCTCGAGGCCACCATGGACTAC
AAAGACC-30 ) and BAF-DN (50-GCTGAATTCGGATCCTCACAAGAAG
GCG-30). This places a XhoI site (italics) upstream and a BamHI site
(underlined) downstream of the ORF, which were used to clone into
the corresponding sites present in pJS4-RFP (Chakrabarti et al., 1997).
Virus and Infections
Virus Preparation
Wild-type vaccinia virus (WR strain), ts2, and ts2:hVrk1 (Boyle and
Traktman, 2004) were grown in BSC40 cells at 37Cor 31.5C, respec-
tively. Viral stocks were prepared from cytoplasmic lysates of infected
cells by ultracentrifugation through 36% sucrose and then titrated on
BSC40 cells. During infections, 31.5 and 39.7C were used as theInc.
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referred to in Figures as 32 and 40C.
24 Hr Yield
Confluent 35 mm-diameter dishes of 293:CAT or 293:BAF cells were
infected at an MOI of 5 and maintained at 31.5 or 39.7C. Cells were
harvested at 24 hpi in 1 mM Tris (pH 9.0). Virus yields were assessed
by plaque assays performed on BSC40 cells at 31.5C. Three separate
experiments were performed, and each was titrated in triplicate; the
average value is shown with standard errors indicated.
Immunofluorescence
293:BAF cells were grown in 1 mg/ml tetracycline for 3 days prior to
plating on chamber slides (Lab-Tek, Naperville, IL) 48 hr before infec-
tion and/or fixation. Infections were performed at an MOI = 5. At 9 hpi,
cells were fixed in 4% PFA, 4% sucrose in phosphate-buffered saline
(PBS; 140 mMNaCl, 2 mM KCL, 10 mMNa2HPO4, 1 mM KH2PO4, [pH
7.4]) at room temperature for 15 min, permeabilized with 0.2% Triton
X-100 in PBS for 5 min at room temperature, and then blocked in
PBS/5% BSA for 30 min. Cells were then incubated with mouse
a-FLAG M2 antibody (Sigma) and rabbit a-I3, both at a dilution of
1:400 in PBS/1% BSA. This was followed by Alexa-fluor 594-conju-
gated goat a-mouse and Alexfluor 488-conjugated goat a-rabbit-488
(Molecular Probes) at 1:500 in PBS/1% BSA. DNA was stained with
DAPI. Proteins were observed by indirect fluorescence on a Nikon
Eclipse TE2000-U microscope (Melville, NY). Images were pseudocol-
ored using MetaMorph software (Sunnyvale, CA) and labeled using
Canvas 8 (Deneba Systems, Miami, FL).
Cell Culture and Reagents
Human thymidine kinase-negative 143B osteosarcoma cells (TK)
and African green monkey BSC40 kidney epithelial cells were main-
tained as monolayers in DMEM, supplemented with 5% fetal bovine
serum (FBS; GIBCO/Invitrogen, Carlsbad, CA) in the presence of 5%
CO2. Human osteosarcoma U2OS cells were maintained in DMEM
with 10% FBS. Flp-In Trex 293 HEK cells were obtained from Invitro-
gen and grown in DMEM with 10% FBS, 50 mg/ml hygromycin, and
7.5mg/ml blasticidin after they had been stably transfected with
pcDNA5/FRT/TO-CAT or3XFLAG-BAF. The following plasmids were
used in this study: p3XFLAG-BAF (Nichols et al., 2006), and pcDNA5/
FRT/TO (Invitrogen). pJS4 was generously provided by B. Moss
(NIAID, Bethesda, MD); the pJS4:RFP derivative was previously
generated in our laboratory by Jason Mercer (unpublished data).
Cell Lysis and Immunoblotting
Approximately 1 3 106 U2OS or BSC40 were transiently transfected
with 1 mg of p3XFLAG-BAF or empty vector using Lipofectamine
2000. 13 106 293:BAF cells were induced to express the relevant pro-
tein with 1 mg/ml tetracycline. At 16 hr posttransfection or postinduc-
tion, the cells were infected with wild-type virus, ts2, or ts2/hVrk1 and
at 5 hpi were resuspended in ice-cold fractionation buffer (20 mM Tris
pH 7.4, 5 mMMgCl2, 5 mM DTT, 150 mM KCl, and 0.5% Triton X-100)
containing 1 mMNaF, 1 mM sodium orthovanadate, 40 mM b-glycerol
phosphate, 1 mg/ml leupeptin, 1 mg/ml pepstatin, and 1 mM PMSF. Af-
ter 10 min of incubation on ice, sucrose was added to 10%, and the
insoluble fraction was retrieved by centrifugation at 1000 3 g for
10 min. The supernatant was resolved by SDS-PAGE and subjected
to immunoblot analysis with a-FLAG M2 antibody. When indicated,
U2OS cells were radiolabeled by replacing the media with phos-
phate-free DMEM (MP Biomedical, Irvine, CA) supplemented with
100 mCi/ml 32PPi from 20 to 24 hr posttransfection, and FLAG-BAF
was then retrieved from the soluble fraction of radiolabeled extracts
using rabbit a-FLAG sepharose, washed, and eluted in SDS sample
buffer before analysis by immunoblot and autoradiography.
Antibodies
Antiserum specific for vaccinia single-stranded binding protein I3 has
been described (Rochester and Traktman, 1998). Rabbit a-BAF anti-
body recognizing total BAF was generously provided by Dr. KatherineCell HWilson (Johns Hopkins University, Baltimore, MD). An antibody spe-
cific for BAF modified by phosphorylated on Ser-4 was generated in
rabbits by Bethyl Laboratories, Inc. (Montgomery, TX). Antibody was
raised against the KLH-conjugated peptide MTT(pS)QKHRDFC, and
phosphospecific antibody was isolated from serum by sequential neg-
ative and positive affinity purification.
Production and Use of shRNA Lentiviruses
The pLL3.7-shBAF construct was produced by annealing the primers
shBAF-UP (50-TGGCCTATGTTGTCCTTGGCTTCAAGAGAGCCAAGG
ACAACATAGGCCTTTTT GGAAAC-30) and shBAF-DN (50-TCGAGTT
TCCAAAAAGGCCTATGTTGT CCTTGGCTCTCTTGAAGCCAAGGAC
AACATAGGCCA-30) and cloning them into the HpaI and XhoI sites of
pLL3.7/Puro (Rubinson et al., 2003). The pLL3.7-Scram construct
was produced by annealing shScram-UP (50-TCAGTCGCGTTTGCGA
CTGGTTCAAGAGACCAGT CGCAAACGCGACTGTTTTTGGAAAC-30)
and shScram-DN (50-TCGAGTTTCCAAAAACAGTCGCGTTTGCGACT
GGTCTCTTGAACCAGTCGCAAACGCGACTGA-30) and cloning the
product into the HpaI and XhoI sites of pLL3.7/Puro. Lentiviruses ex-
pressing shRNAs were produced in 293T cells following transfection
with either pLL3.7, pLL3.7-shBAF, or pLL3.7-shScram in combination
with pMD2.G, pRSV REV, and pMDLg/pRRE encoding the VSV-G,
Rev, andGag/Pol genes, respectively. At 16 hr post transfection, fresh
media was added to cells. At 48 hr post transfection, the media con-
taining recombinant virus was harvested, polybrene was added to 8
mg/ml, and stocks were aliquoted for storage at –80C.
To inhibit BAF expression, 293:CAT cells were infected with lentivi-
rus containing pLL3.7,shBAF, or –shScram for 24 hr, followed by se-
lection of stable integrants in the presence of 5 mg/ml puromycin. At 96
hpi with lentivirus, cells were infected with either wt or ts2 vaccinia
virus (MOI = 5) and placed at 31.5C or 39.7C for 24 hr. Cells were
then harvested and the yield of vaccinia virus was determined. Alterna-
tively, at 96 hpi with lentivirus, cells were harvested and the rabbit
a-BAF antibody was used in immunoblot analysis to assess the extent
of BAF depletion.
Dot Blot Hybridization to Assess Viral DNA Accumulation
Confluent 35 mm-diameter dishes of 293:CAT or 293:BAF cells were
infected with WT virus or ts2 at an MOI of 5 and incubated at 31.5 or
39.7C. Cells were harvested at the indicated time points (3, 7, 9,
and 12 hpi). Subsequent lysis of the cells and dot blot hybridization
was performed as previously described (Boyle and Traktman, 2004).
Production of Recombinant BAF and Use in Nick Translation
Studies
Dimeric BAF was expressed and purified from BL21(DE3)pLysS cells
as described (Nichols et al., 2006). BAF was phosphorylated in vitro
using purified, recombinant B1 kinase (or included in mock reactions
containing no kinase) under conditions known to phosphorylate BAF
to completion (Nichols et al., 2006). These reactions were used as
the source of BAF in the nick translation reactions described below.
Nick translation reactions (11 ml) were assembled by first combining
the pBR322:vvHindIII E plasmid, unlabeled GTP andCTP, radiolabeled
ATP and TTP, and DNase I (200 ng/ml final concentration) on ice. Var-
ious amounts of phosphorylated or unphosphorylated recombinant
BAF (0, 10, 30, 100, and 350 ng) were then added to the reactions,
which were moved to room temperature for 10 min. DNA Polymerase
I (New England Biolabs, Ipswitch, MA) was then added to the reac-
tions, whichwere then placed at 16C for 1 hr. Reactions were stopped
by the addition of 40 ml of TE buffer and placed on ice; unincorporated
nucleotides were removed by size exclusion spin chromatography.
DNA synthesis, as reflected by the incorporation of radiolabeled
dNTPs into DNA, was quantified by C¸erenkov counting.
Supplemental Data
The Supplemental Data include four supplemental figures and can be
found with this article online at http://www.cellhostandmicrobe.com/
cgi/content/full/1/3/187/DC1/.ost & Microbe 1, 187–197, May 2007 ª2007 Elsevier Inc. 195
Cell Host & Microbe
BAF: Innate Host Defense Overcome by Pox B1 KinaseACKNOWLEDGMENTS
We thank Drs. Kathy Boyle, Stephen Duncan, Amy Hudson, and R.
Jeremy Nichols for critical analysis and comments during the prepara-
tion of this manuscript. This work was supported by a postdoctoral
grant to M.S.W. from the Great Lakes Regional Center for Excellence
in Biodefense and Emerging Infectious Diseases (U54 AI-057153) and
by grants to P.T. from the NIH (2 R01 AI 21758) and the MCW Advanc-
ing a Healthier Wisconsin Program.
Received: October 19, 2006
Revised: February 12, 2007
Accepted: March 25, 2007
Published: May 16, 2007
REFERENCES
Banham, A.H., and Smith, G.L. (1992). Vaccinia virus gene B1R
encodes a 34-kDa serine/threonine protein kinase that localizes in
cytoplasmic factories and is packaged into virions. Virology 191,
803–812.
Bengtsson, L., and Wilson, K.L. (2006). Barrier-to-autointegration fac-
tor phosphorylation on Ser-4 regulates emerin binding to lamin A
in vitro and emerin localization in vivo. Mol. Biol. Cell 17, 1154–1163.
Birthistle, K., and Carrington, D. (1997). Molluscum contagiosum virus.
J. Infect. 34, 21–28.
Boyle, K., and Traktman, P. (2004). Members of a novel family of mam-
malian protein kinases complement the DNA-negative phenotype of
a vaccinia virus ts mutant defective in the B1 kinase. J. Virol. 78,
1992–2005.
Bradley, C.M., Ronning, D.R., Ghirlando, R., Craigie, R., and Dyda, F.
(2005). Structural basis for DNA bridging by barrier-to-autointegration
factor. Nat. Struct. Mol. Biol. 12, 935–936.
Chakrabarti, S., Sisler, J.R., and Moss, B. (1997). Compact, synthetic,
vaccinia virus early/late promoter for protein expression. Biotechni-
ques 23, 1094–1097.
Chen, H., and Engelman, A. (1998). The barrier-to-autointegration pro-
tein is a host factor for HIV type 1 integration. Proc. Natl. Acad. Sci.
USA 95, 15270–15274.
Furukawa, K., Sugiyama, S., Osouda, S., Goto, H., Inagaki, M., Hori-
gome, T., Omata, S., McConnell, M., Fisher, P.A., and Nishida, Y.
(2003). Barrier-to-autointegration factor plays crucial roles in cell cycle
progression and nuclear organization in Drosophila. J. Cell Sci. 116,
3811–3823.
Gorjanacz, M., Klerkx, E.P., Galy, V., Santarella, R., Lopez-Iglesias, C.,
Askjaer, P., andMattaj, I.W. (2007). Caenorhabditis elegans BAF-1 and
its kinase VRK-1 participate directly in post-mitotic nuclear envelope
assembly. EMBO J. 26, 132–143.
Haraguchi, T., Koujin, T., Segura-Totten, M., Lee, K.K., Matsuoka, Y.,
Yoneda, Y., Wilson, K.L., and Hiraoka, Y. (2001). BAF is required for
emerin assembly into the reforming nuclear envelope. J. Cell Sci.
114, 4575–4585.
Harris, D., and Engelman, A. (2000). Both the structure and DNA bind-
ing function of the barrier-to-autointegration factor contribute to
reconstitution of HIV type 1 integration in vitro. J. Biol. Chem. 275,
39671–39677.
Ishii, K.J., Coban, C., Kato, H., Takahashi, K., Torii, Y., Takeshita, F.,
Ludwig, H., Sutter, G., Suzuki, K., Hemmi, H., et al. (2006). A Toll-like
receptor-independent antiviral response induced by double-stranded
B-form DNA. Nat. Immunol. 7, 40–48.
Jacque, J.M., and Stevenson, M. (2006). The inner-nuclear-envelope
protein emerin regulates HIV-1 infectivity. Nature 441, 641–645.
Lee, M.S., and Craigie, R. (1998). A previously unidentified host protein
protects retroviral DNA from autointegration. Proc. Natl. Acad. Sci.
USA 95, 1528–1533.196 Cell Host & Microbe 1, 187–197, May 2007 ª2007 Elsevier ILin, C.W., and Engelman, A. (2003). The barrier-to-autointegration
factor is a component of functional human immunodeficiency virus
type 1 preintegration complexes. J. Virol. 77, 5030–5036.
Lin, S., Chen, W., and Broyles, S.S. (1992). The vaccinia virus B1R
gene product is a serine/threonine protein kinase. J. Virol. 66, 2717–
2723.
Lopez-Borges, S., and Lazo, P.A. (2000). The human vaccinia-related
kinase 1 (VRK1) phosphorylates threonine-18 within the mdm-2 bind-
ing site of the p53 tumour suppressor protein. Oncogene 19, 3656–
3664.
Mansharamani, M., Graham, D.R., Monie, D., Lee, K.K., Hildreth, J.E.,
Siliciano, R.F., and Wilson, K.L. (2003). Barrier-to-autointegration fac-
tor BAF binds p55 Gag and matrix and is a host component of human
immunodeficiency virus type 1 virions. J. Virol. 77, 13084–13092.
Margalit, A., Segura-Totten, M., Gruenbaum, Y., and Wilson, K.L.
(2005). Barrier-to-autointegration factor is required to segregate and
enclose chromosomes within the nuclear envelope and assemble
the nuclear lamina. Proc. Natl. Acad. Sci. USA 102, 3290–3295.
Meylan, E., and Tschopp, J. (2006). Toll-like receptors and RNA heli-
cases: two parallel ways to trigger antiviral responses. Mol. Cell 22,
561–569.
Nichols, R.J., and Traktman, P. (2004). Characterization of three paral-
ogous members of the Mammalian vaccinia related kinase family.
J. Biol. Chem. 279, 7934–7946.
Nichols, R.J., Wiebe, M.S., and Traktman, P. (2006). The vaccinia-
related kinases phosphorylate the N’ terminus of BAF, regulating its
interaction with DNA and its retention in the nucleus. Mol. Biol. Cell
17, 2451–2464.
Oda, K., and Joklik, W.K. (1967). Hybridization and sedimentation
studies on early and late vaccinia messenger RNA. J. Mol. Biol. 27,
395–419.
Rempel, R.E., Anderson, M.K., Evans, E., and Traktman, P. (1990).
Temperature-sensitive vaccinia virus mutants identify a gene with an
essential role in viral replication. J. Virol. 64, 574–583.
Rempel, R.E., and Traktman, P. (1992). Vaccinia virus B1 kinase: phe-
notypic analysis of temperature-sensitive mutants and enzymatic
characterization of recombinant proteins. J. Virol. 66, 4413–4426.
Rochester, S.C., and Traktman, P. (1998). Characterization of the sin-
gle-stranded DNA binding protein encoded by the vaccinia virus I3
gene. J. Virol. 72, 2917–2926.
Rubinson, D.A., Dillon, C.P., Kwiatkowski, A.V., Sievers, C., Yang, L.,
Kopinja, J., Rooney, D.L., Ihrig, M.M., McManus, M.T., Gertler, F.B.,
et al. (2003). A lentivirus-based system to functionally silence genes
in primary mammalian cells, stem cells and transgenic mice by RNA
interference. Nat. Genet. 33, 401–406.
Segura-Totten, M., Kowalski, A.K., Craigie, R., andWilson, K.L. (2002).
Barrier-to-autointegration factor: major roles in chromatin deconden-
sation and nuclear assembly. J. Cell Biol. 158, 475–485.
Segura-Totten, M., and Wilson, K.L. (2004). BAF: roles in chromatin,
nuclear structure and retrovirus integration. Trends Cell Biol. 14,
261–266.
Shumaker, D.K., Lee, K.K., Tanhehco, Y.C., Craigie, R., and Wilson,
K.L. (2001). LAP2 binds to BAF.DNA complexes: requirement for the
LEM domain and modulation by variable regions. EMBO J. 20,
1754–1764.
Shun, M.C., Daigle, J.E., Vandegraaff, N., and Engelman, A. (2007).
Wild-type levels of human immunodeficiency virus type 1 infectivity
in the absence of cellular emerin protein. J. Virol. 88, 166–172. Pub-
lished online October 11, 2006. 10.1128/JVI.01953-06.
Stetson, D.B., and Medzhitov, R. (2006). Recognition of cytosolic DNA
activates an IRF3-dependent innate immune response. Immunity 24,
93–103.
Suzuki, Y., and Craigie, R. (2002). Regulatory mechanisms by which
barrier-to-autointegration factor blocks autointegration and stimulatesnc.
Cell Host & Microbe
BAF: Innate Host Defense Overcome by Pox B1 Kinaseintermolecular integration of Moloney murine leukemia virus preinte-
gration complexes. J. Virol. 76, 12376–12380.
Tifft, K.E., Segura-Totten, M., Lee, K.K., and Wilson, K.L. (2006). Bar-
rier-to-autointegration factor-like (BAF-L): a proposed regulator of
BAF. Exp. Cell Res. 312, 478–487.
Vasselon, T., and Detmers, P.A. (2002). Toll receptors: a central ele-
ment in innate immune responses. Infect. Immun. 70, 1033–1041.Cell HWagner, H., and Bauer, S. (2006). All is not Toll: new pathways in DNA
recognition. J. Exp. Med. 203, 265–268.
Zheng, R., Ghirlando, R., Lee,M.S., Mizuuchi, K., Krause, M., and Crai-
gie, R. (2000). Barrier-to-autointegration factor (BAF) bridges DNA in
a discrete, higher-order nucleoprotein complex. Proc. Natl. Acad.
Sci. USA 97, 8997–9002.ost & Microbe 1, 187–197, May 2007 ª2007 Elsevier Inc. 197
